Interpace Biosciences, Inc. - Laporan Laba Rugi (TTM)

Interpace Biosciences, Inc.
US ˙ OTCPK ˙ US46062X3035

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Interpace Biosciences, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 27 32 33 34 34 33 31 32 33 32 34 37 38 40 40 41 45 47 48 45
Change (%) 20.14 2.39 2.02 -0.56 -1.59 -5.77 4.10 0.40 -2.39 5.98 10.76 2.38 4.63 0.88 2.51 7.77 5.17 2.85 -5.82
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 21 22 21 18 17 14 12 15 14 14 14 15 15 15 15 15 16 17 17 17
Change (%) 5.44 -3.68 -12.36 -8.60 -14.40 -14.33 18.72 -1.13 -5.47 4.28 4.41 4.51 -3.25 0.13 0.29 4.42 8.23 1.64 -1.61
% of Revenue 76.22 66.90 62.93 54.06 49.69 43.22 39.30 44.82 44.13 42.74 42.06 39.64 40.47 37.42 37.14 36.33 35.20 36.23 35.80 37.40
Gross Operating Profit 6 11 12 16 17 19 19 18 18 18 20 23 23 25 25 26 29 30 31 28
Change (%) 67.26 14.65 26.45 8.89 11.06 0.75 -5.37 1.65 0.05 7.24 15.38 0.98 10.00 1.33 3.82 9.68 3.51 3.54 -8.17
% of Revenue 23.78 33.10 37.07 45.94 50.31 56.78 60.70 55.18 55.87 57.26 57.94 60.36 59.53 62.58 62.86 63.67 64.80 63.77 64.20 62.60
SG&A 27 27 25 24 22 20 20 21 21 20 20 20 19 20 20 19 20 21 21 22
Change (%) 0.91 -7.24 -5.49 -7.29 -10.87 -1.23 6.89 0.92 -5.13 -1.24 -0.17 -1.92 0.83 1.14 -2.38 4.03 5.04 1.44 2.53
% of Revenue 100.86 84.72 76.75 71.09 66.29 60.04 62.93 64.62 64.95 63.13 58.82 53.02 50.79 48.95 49.07 46.73 45.11 45.05 44.43 48.37
R&D 3 3 3 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Change (%) -3.65 -6.15 -12.66 -19.25 -19.30 -27.19 -1.38 -12.22 -25.29 -11.66 -2.90 -6.97 13.37 -1.89 -6.41 8.56 6.62 5.92 3.77
% of Revenue 10.76 8.63 7.91 6.77 5.50 4.51 3.48 3.30 2.88 2.21 1.84 1.61 1.47 1.59 1.55 1.41 1.42 1.44 1.48 1.63
OpEx 55 56 53 48 44 39 35 39 38 36 36 37 37 36 36 35 36 39 39 40
Change (%) 2.29 -5.25 -9.33 -8.24 -12.51 -8.99 9.92 -1.74 -6.65 0.70 1.60 0.35 -1.52 -0.24 -2.18 3.68 6.36 1.60 0.74
% of Revenue 204.38 174.01 161.02 143.10 132.06 117.40 113.39 119.73 117.18 112.06 106.48 97.67 95.73 90.10 89.10 85.02 81.79 82.72 81.72 87.41
Operating Income -28 -24 -20 -15 -11 -6 -4 -6 -6 -4 -2 1 2 4 4 6 8 8 9 6
Change (%) -14.82 -15.57 -27.94 -26.04 -46.58 -27.50 53.41 -12.62 -31.45 -43.02 -139.76 87.70 142.68 11.08 40.87 31.00 -0.18 8.82 -35.12
% of Revenue -104.38 -74.01 -61.02 -43.10 -32.06 -17.40 -13.39 -19.73 -17.18 -12.06 -6.48 2.33 4.27 9.90 10.90 14.98 18.21 17.28 18.28 12.59
Interest Expense -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -0
Change (%) 4.97 21.49 14.39 15.60 17.91 7.12 -7.99 1.07 -2.70 -4.07 8.79 -1.24 -2.98 -4.37 -7.47 -12.33 -15.73 -20.94 -26.49
% of Revenue -1.94 -1.69 -2.01 -2.25 -2.62 -3.14 -3.57 -3.16 -3.18 -3.17 -2.87 -2.81 -2.72 -2.52 -2.39 -2.15 -1.75 -1.40 -1.08 -0.84
Net Income -29 -26 -24 -22 -19 -15 -13 -13 -24 -22 -19 -15 -2 2 2 5 6 7 8 5
Change (%) -8.70 -8.65 -8.83 -12.13 -22.80 -13.12 3.80 79.01 -8.97 -11.83 -21.25 -89.16 -218.28 18.27 97.88 41.42 3.63 14.01 -40.27
% of Revenue -107.43 -81.64 -72.84 -65.09 -57.52 -45.12 -41.60 -41.48 -73.96 -68.97 -57.38 -40.79 -4.32 4.88 5.72 11.05 14.49 14.28 15.83 10.04

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista